Detalhe da pesquisa
1.
Breast cancer genomes from CHEK2 c.1100delC mutation carriers lack somatic TP53 mutations and display a unique structural variant size distribution profile.
Breast Cancer Res;
25(1): 53, 2023 05 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37161532
2.
The circular RNome of primary breast cancer.
Genome Res;
29(3): 356-366, 2019 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30692147
3.
Functional Homologous Recombination (HR) Screening Shows the Majority of BRCA1/2-Mutant Breast and Ovarian Cancer Cell Lines Are HR-Proficient.
Cancers (Basel);
16(4)2024 Feb 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38398132
4.
miRNA expression profiling of 51 human breast cancer cell lines reveals subtype and driver mutation-specific miRNAs.
Breast Cancer Res;
15(2): R33, 2013 Apr 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23601657
5.
Expression and Localization of Ferritin-Heavy Chain Predicts Recurrence for Breast Cancer Patients with a BRCA1/2 Mutation.
Cancers (Basel);
16(1)2023 Dec 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38201455
6.
A pipeline for copy number profiling of single circulating tumour cells to assess intrapatient tumour heterogeneity.
Mol Oncol;
16(16): 2981-3000, 2022 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34964258
7.
Metabotropic glutamate receptor 1 is associated with unfavorable prognosis in ER-negative and triple-negative breast cancer.
Sci Rep;
10(1): 22292, 2020 12 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33339858
8.
Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.
Sci Rep;
10(1): 9688, 2020 06 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32546843
9.
MicroRNAs as possible indicators of drug sensitivity in breast cancer cell lines.
PLoS One;
14(5): e0216400, 2019.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31063487
10.
GATA3 mRNA expression, but not mutation, associates with longer progression-free survival in ER-positive breast cancer patients treated with first-line tamoxifen for recurrent disease.
Cancer Lett;
376(1): 104-9, 2016 06 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27018307
11.
Recurrent HOXB13 mutations in the Dutch population do not associate with increased breast cancer risk.
Sci Rep;
6: 30026, 2016 07 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27424772
12.
Breast cancer genome and transcriptome integration implicates specific mutational signatures with immune cell infiltration.
Nat Commun;
7: 12910, 2016 Sep 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27666519
13.
Understanding drugs in breast cancer through drug sensitivity screening.
Springerplus;
4: 611, 2015.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26543746
14.
CD49f-based selection of circulating tumor cells (CTCs) improves detection across breast cancer subtypes.
Cancer Lett;
319(1): 49-55, 2012 Jun 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22202642